This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Radium-223 Dichloride (Alpharadin) in Castration-R...
Clinical trial

Radium-223 Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients with Bone Metastasis

Read time: 1 mins
Last updated:12th Jun 2012
To assess acute and long-term safety and overall survival in patients with castration-resistant (hormone-refractory) prostate cancer.
Category Value
Study start date 2012-06-12

View full details